Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Emergence of ceftazidime-avibactam-resistant Klebsiella pneumoniae during treatment, Finland, December 2018.

Räisänen K, Koivula I, Ilmavirta H, Puranen S, Kallonen T, Lyytikäinen O, Jalava J.

Euro Surveill. 2019 May;24(19). doi: 10.2807/1560-7917.ES.2019.24.19.1900256.

2.

Sharing more than friendship - transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between dogs and humans in a family, Finland, 2015.

Grönthal T, Österblad M, Eklund M, Jalava J, Nykäsenoja S, Pekkanen K, Rantala M.

Euro Surveill. 2018 Jul;23(27). doi: 10.2807/1560-7917.ES.2018.23.27.1700497.

3.

Impact of Antimicrobial Treatment for Acute Otitis Media on Carriage Dynamics of Penicillin-Susceptible and Penicillin-Nonsusceptible Streptococcus pneumoniae.

Lewnard JA, Tähtinen PA, Laine MK, Lindholm L, Jalava J, Huovinen P, Lipsitch M, Ruohola A.

J Infect Dis. 2018 Sep 22;218(9):1356-1366. doi: 10.1093/infdis/jiy343.

PMID:
29873739
4.

The first human report of mobile colistin resistance gene, mcr-1, in Finland.

Gröndahl-Yli-Hannuksela K, Lönnqvist E, Kallonen T, Lindholm L, Jalava J, Rantakokko-Jalava K, Vuopio J.

APMIS. 2018 May;126(5):413-417. doi: 10.1111/apm.12834.

PMID:
29696722
5.

The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.

Krutova M, Nyc O, Matejkova J, Kuijper EJ, Jalava J, Mentula S.

J Microbiol Immunol Infect. 2018 Jun;51(3):344-351. doi: 10.1016/j.jmii.2017.02.002. Epub 2017 May 24.

6.

Sequence analysis of pooled bacterial samples enables identification of strain variation in group A streptococcus.

Weldatsadik RG, Wang J, Puhakainen K, Jiao H, Jalava J, Räisänen K, Datta N, Skoog T, Vuopio J, Jokiranta TS, Kere J.

Sci Rep. 2017 Mar 31;7:45771. doi: 10.1038/srep45771.

7.

Genomic Characteristics Behind the Spread of Bacteremic Group A Streptococcus Type emm89 in Finland, 2004-2014.

Latronico F, Nasser W, Puhakainen K, Ollgren J, Hyyryläinen HL, Beres SB, Lyytikäinen O, Jalava J, Musser JM, Vuopio J.

J Infect Dis. 2016 Dec 15;214(12):1987-1995. Epub 2016 Oct 5.

8.

Transcriptome Remodeling Contributes to Epidemic Disease Caused by the Human Pathogen Streptococcus pyogenes.

Beres SB, Kachroo P, Nasser W, Olsen RJ, Zhu L, Flores AR, de la Riva I, Paez-Mayorga J, Jimenez FE, Cantu C, Vuopio J, Jalava J, Kristinsson KG, Gottfredsson M, Corander J, Fittipaldi N, Di Luca MC, Petrelli D, Vitali LA, Raiford A, Jenkins L, Musser JM.

MBio. 2016 May 31;7(3). pii: e00403-16. doi: 10.1128/mBio.00403-16.

9.

Evaluation of two commercial carbapenemase gene assays, the Rapidec Carba NP test and the in-house Rapid Carba NP test, on bacterial cultures.

Österblad M, Lindholm L, Jalava J.

J Antimicrob Chemother. 2016 Jul;71(7):2057-9. doi: 10.1093/jac/dkw077. Epub 2016 Mar 31. No abstract available.

PMID:
27037274
10.

Rare Detection of the Acinetobacter Class D Carbapenemase blaOXA-23 Gene in Proteus mirabilis.

Österblad M, Karah N, Halkilahti J, Sarkkinen H, Uhlin BE, Jalava J.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3243-5. doi: 10.1128/AAC.03119-15. Print 2016 May. No abstract available.

11.

Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.

Martelius T, Jalava J, Kärki T, Möttönen T, Ollgren J, Lyytikäinen O; Hospital Infection Surveillance team.

Infect Dis (Lond). 2016;48(3):229-34. doi: 10.3109/23744235.2015.1109135. Epub 2015 Nov 18.

PMID:
26577519
12.

Epidemiology and emm types of invasive group A streptococcal infections in Finland, 2008-2013.

Smit PW, Lindholm L, Lyytikäinen O, Jalava J, Pätäri-Sampo A, Vuopio J.

Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2131-6. doi: 10.1007/s10096-015-2462-2. Epub 2015 Aug 21.

PMID:
26292935
13.

Coincidental detection of the first outbreak of carbapenemase-producing Klebsiella pneumoniae colonisation in a primary care hospital, Finland, 2013.

Kanerva M, Skogberg K, Ryynänen K, Pahkamäki A, Jalava J, Ollgren J, Tarkka E, Lyytikäinen O.

Euro Surveill. 2015 Jul 2;20(26). pii: 21172.

14.

Evaluation of the Carba NP test for carbapenemase detection.

Osterblad M, Hakanen AJ, Jalava J.

Antimicrob Agents Chemother. 2014 Dec;58(12):7553-6. doi: 10.1128/AAC.02761-13. Epub 2014 Sep 22.

15.

Cefotaxime-resistant Salmonella enterica in travelers returning from Thailand to Finland.

Gunell M, Aulu L, Jalava J, Lukinmaa-Åberg S, Osterblad M, Ollgren J, Huovinen P, Siitonen A, Hakanen AJ.

Emerg Infect Dis. 2014 Jul;20(7):1214-7. doi: 10.3201/eid2007.131744.

16.

An outbreak of CTX-M-15 -producing Escherichia coli, Enterobacter cloacae, and Klebsiella in a children's hospital in Finland.

Pasanen T, Jalava J, Horsma J, Salo E, Pakarinen M, Tarkka E, Vaara M, Tissari P.

Scand J Infect Dis. 2014 Mar;46(3):225-30. doi: 10.3109/00365548.2013.857045. Epub 2013 Dec 5.

PMID:
24303912
17.

Antimicrobial resistance in relation to sero- and genotypes among invasive Streptococcus pneumoniae in Finland, 2007-2011.

Siira L, Jalava J, Kaijalainen T, Ollgren J, Lyytikäinen O, Virolainen A.

Microb Drug Resist. 2014 Apr;20(2):124-30. doi: 10.1089/mdr.2013.0156. Epub 2013 Nov 22.

PMID:
24266666
18.

Clostridium difficile contamination of public tap water distribution system during a waterborne outbreak in Finland.

Kotila SM, Pitkänen T, Brazier J, Eerola E, Jalava J, Kuusi M, Könönen E, Laine J, Miettinen IT, Vuento R, Virolainen A.

Scand J Public Health. 2013 Jul;41(5):541-5. doi: 10.1177/1403494813481648. Epub 2013 Mar 15.

PMID:
23503193
19.

Bacterial and viral interactions within the nasopharynx contribute to the risk of acute otitis media.

Ruohola A, Pettigrew MM, Lindholm L, Jalava J, Räisänen KS, Vainionpää R, Waris M, Tähtinen PA, Laine MK, Lahti E, Ruuskanen O, Huovinen P.

J Infect. 2013 Mar;66(3):247-54. doi: 10.1016/j.jinf.2012.12.002. Epub 2012 Dec 22.

20.

Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11).

Österblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J.

J Antimicrob Chemother. 2012 Dec;67(12):2860-4. doi: 10.1093/jac/dks299. Epub 2012 Jul 31.

PMID:
22855858
21.

Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli.

Lehtopolku M, Kotilainen P, Haanperä-Heikkinen M, Nakari UM, Hänninen ML, Huovinen P, Siitonen A, Eerola E, Jalava J, Hakanen AJ.

Antimicrob Agents Chemother. 2011 Dec;55(12):5939-41. doi: 10.1128/AAC.00314-11. Epub 2011 Sep 12.

22.

Clonality behind the increase of multidrug-resistance among non-invasive pneumococci in Southern Finland.

Siira L, Jalava J, Tissari P, Vaara M, Kaijalainen T, Virolainen A.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):867-71. doi: 10.1007/s10096-011-1386-8. Epub 2011 Aug 26.

PMID:
21870053
23.

Detection of Streptococcus pneumoniae carriage by the Binax NOW test with nasal and nasopharyngeal swabs in young children.

Vuorenoja K, Jalava J, Lindholm L, Tähtinen PA, Laine MK, Thorn K, Ruohola A.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):703-6. doi: 10.1007/s10096-011-1361-4. Epub 2011 Jul 30.

PMID:
21800217
24.

A placebo-controlled trial of antimicrobial treatment for acute otitis media.

Tähtinen PA, Laine MK, Huovinen P, Jalava J, Ruuskanen O, Ruohola A.

N Engl J Med. 2011 Jan 13;364(2):116-26. doi: 10.1056/NEJMoa1007174.

25.

Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008.

Kotila SM, Virolainen A, Snellman M, Ibrahem S, Jalava J, Lyytikäinen O.

Clin Microbiol Infect. 2011 Jun;17(6):888-93. doi: 10.1111/j.1469-0691.2010.03384.x. Epub 2010 Nov 10.

26.

Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland.

Forssten SD, Kolho E, Lauhio A, Lehtola L, Mero S, Oksaharju A, Jalava J, Tarkka E, Vaara M, Vuopio-Varkila J.

Clin Microbiol Infect. 2010 Aug;16(8):1158-61. doi: 10.1111/j.1469-0691.2010.03068.x.

27.

Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland.

Siljander T, Lyytikäinen O, Vähäkuopus S, Snellman M, Jalava J, Vuopio J.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1229-35. doi: 10.1007/s10096-010-0989-9. Epub 2010 Jun 20.

PMID:
20563620
28.

Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change.

Alam C, Valkonen S, Palagani V, Jalava J, Eerola E, Hänninen A.

Diabetes. 2010 Sep;59(9):2237-46. doi: 10.2337/db10-0147. Epub 2010 Jun 14.

29.

In vitro activity of azithromycin against nontyphoidal Salmonella enterica.

Gunell M, Kotilainen P, Jalava J, Huovinen P, Siitonen A, Hakanen AJ.

Antimicrob Agents Chemother. 2010 Aug;54(8):3498-501. doi: 10.1128/AAC.01678-09. Epub 2010 May 24.

30.

Comparison of repetitive extragenic palindromic sequence-based PCR with PCR ribotyping and pulsed-field gel electrophoresis in studying the clonality of Clostridium difficile.

Pasanen T, Kotila SM, Horsma J, Virolainen A, Jalava J, Ibrahem S, Antikainen J, Mero S, Tarkka E, Vaara M, Tissari P.

Clin Microbiol Infect. 2011 Feb;17(2):166-75. doi: 10.1111/j.1469-0691.2010.03221.x.

31.

First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009.

Osterblad M, Kirveskari J, Koskela S, Tissari P, Vuorenoja K, Hakanen AJ, Vaara M, Jalava J.

Euro Surveill. 2009 Oct 8;14(40). pii: 19349.

32.

Hidden qnrB12 gene in a Finnish faecal microbiota isolate from 1994.

Gunell M, Hakanen AJ, Jalava J, Huovinen P, Osterblad M.

J Antimicrob Chemother. 2009 Oct;64(4):861-2. doi: 10.1093/jac/dkp304. Epub 2009 Aug 19. No abstract available.

PMID:
19692413
33.

Clostridium difficile ribotype 027-associated disease in children with norovirus infection.

Lukkarinen H, Eerola E, Ruohola A, Vainionpää R, Jalava J, Kotila S, Ruuskanen O.

Pediatr Infect Dis J. 2009 Sep;28(9):847-8. doi: 10.1097/INF.0b013e31819d1cd9.

PMID:
19636284
34.

Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.

Gunell M, Webber MA, Kotilainen P, Lilly AJ, Caddick JM, Jalava J, Huovinen P, Siitonen A, Hakanen AJ, Piddock LJ.

Antimicrob Agents Chemother. 2009 Sep;53(9):3832-6. doi: 10.1128/AAC.00121-09. Epub 2009 Jul 13.

35.

Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.

Siira L, Rantala M, Jalava J, Hakanen AJ, Huovinen P, Kaijalainen T, Lyytikäinen O, Virolainen A.

Antimicrob Agents Chemother. 2009 May;53(5):2066-73. doi: 10.1128/AAC.01464-08. Epub 2009 Mar 9.

36.

Prolonged impact of a one-week course of clindamycin on Enterococcus spp. in human normal microbiota.

Lindgren M, Lofmark S, Edlund C, Huovinen P, Jalava J.

Scand J Infect Dis. 2009;41(3):215-9. doi: 10.1080/00365540802651897.

PMID:
19107676
37.

Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland.

Siljander T, Lyytikäinen O, Vähäkuopus S, Säilä P, Jalava J, Vuopio-Varkila J.

J Clin Microbiol. 2009 Feb;47(2):477-80. doi: 10.1128/JCM.01663-08. Epub 2008 Dec 10.

38.

Induced sputum in the diagnosis of childhood community-acquired pneumonia.

Lahti E, Peltola V, Waris M, Virkki R, Rantakokko-Jalava K, Jalava J, Eerola E, Ruuskanen O.

Thorax. 2009 Mar;64(3):252-7. doi: 10.1136/thx.2008.099051. Epub 2008 Dec 3.

PMID:
19052043
39.

Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.

Koort JK, Makinen TJ, Suokas E, Veiranto M, Jalava J, Tormala P, Aro HT.

Acta Orthop. 2008 Apr;79(2):295-301. doi: 10.1080/17453670710015111.

PMID:
18484258
40.

Typing of SHV extended-spectrum beta-lactamases by pyrosequencing in Klebsiella pneumoniae strains with chromosomal SHV beta-lactamase.

Haanperä M, Forssten SD, Huovinen P, Jalava J.

Antimicrob Agents Chemother. 2008 Jul;52(7):2632-5. doi: 10.1128/AAC.01259-07. Epub 2008 May 5.

41.

Ciprofloxacin induces mutagenesis to antibiotic resistance independent of UmuC in Streptococcus uberis.

Varhimo E, Savijoki K, Jefremoff H, Jalava J, Sukura A, Varmanen P.

Environ Microbiol. 2008 Aug;10(8):2179-83. doi: 10.1111/j.1462-2920.2008.01634.x. Epub 2008 Apr 23.

PMID:
18430157
42.

Laboratory measurements and T-matrix calculations of the scattering matrix of rutile particles in water.

Volten H, Jalava JP, Lumme K, de Haan JF, Vassen W, Hovenier JW.

Appl Opt. 1999 Aug 20;38(24):5232-40.

PMID:
18324023
44.

Long-term antimicrobial resistance in Escherichia coli from human intestinal microbiota after administration of clindamycin.

Nyberg SD, Osterblad M, Hakanen AJ, Löfmark S, Edlund C, Huovinen P, Jalava J.

Scand J Infect Dis. 2007;39(6-7):514-20.

PMID:
17577812
45.

In vitro susceptibility of viridans group streptococci isolated from blood in southwest Finland in 1993-2004.

Lindgren M, Jalava J, Rantakokko-Jalava K, Meurman O.

Scand J Infect Dis. 2007;39(6-7):508-13.

PMID:
17577811
46.

Identification of a novel streptococcal gene cassette mediating SOS mutagenesis in Streptococcus uberis.

Varhimo E, Savijoki K, Jalava J, Kuipers OP, Varmanen P.

J Bacteriol. 2007 Jul;189(14):5210-22. Epub 2007 May 18.

47.

Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004.

Nyberg SD, Osterblad M, Hakanen AJ, Huovinen P, Jalava J; The Finnish Study Group For Antimicrobial Resistance.

Scand J Infect Dis. 2007;39(5):417-24.

PMID:
17464864
48.

Molecular epidemiology of telithromycin-resistant pneumococci in Finland.

Rantala M, Nyberg S, Lindgren M, Huovinen P, Jalava J, Skyttä R, Teirilä L, Vainio A, Virolainen-Julkunen A, Kaijalainen T.

Antimicrob Agents Chemother. 2007 May;51(5):1885-7. Epub 2007 Feb 26. No abstract available.

49.

Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2.

Haanperä M, Jalava J, Huovinen P, Meurman O, Rantakokko-Jalava K.

J Clin Microbiol. 2007 Mar;45(3):762-70. Epub 2007 Jan 10.

50.

Pneumolysin polymerase chain reaction for diagnosis of pneumococcal pneumonia and empyema in children.

Lahti E, Mertsola J, Kontiokari T, Eerola E, Ruuskanen O, Jalava J.

Eur J Clin Microbiol Infect Dis. 2006 Dec;25(12):783-9.

PMID:
17089094

Supplemental Content

Loading ...
Support Center